Safety, Tolerability, and Immunogenicity of Zika Vaccine mRNA-1893 in Healthy Flavivirus Seropositive and Seronegative Adults
Clinical trial NCT04064905 · COMPLETED
Trial details
- NCT number
- NCT04064905
- Sponsor
- ModernaTX, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-30
- Primary completion
- 2021-03-22
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.